Virucidal activity of Colombian Lippia essential oils on dengue virus replication in vitro

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 3, 2010, Pages 304-309

  Ocazionez, Raquel Elvira ^a   Meneses, Rocio ^a   Torres, Flor Ángela ^a   Stashenko, Elena ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Antiviral; Dengue virus; Essential oil; Lippia sp; Virucidal activity

Indexed keywords

ALOYSIA TRIPHYLLA; DENGUE VIRUS; LIPPIA; LIPPIA ALBA;

EID: 77953513990     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000300010     Document Type: Article

References (34)

1. Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, schols D 2009. Antiviral activity of carbohydrate-binding agents and the role of DC-sIGN in dengue virus infection. Virology 387: 67-75.
2. Carson C, Ashton L, Dry L, smith D, Riley T 2001. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Amtimicrob Chemother 48: 450-451.
3. Cos P, Vlietinck A, Berghe D, Maes L 2006. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol 106: 290-302.
4. Duschatzky C, Possetto M, Talarico L, Garcia C, Michis F, Almeida N, de Lampasona M, schuff C, Damonte E 2005. Evaluation of chemical and antiviral properties of essential oils from south American plants. Antiviral Chem Chemother 16: 247-251.
5. Garcia C, Talarico L, Almeida N, Colombres S, Duschatzky C, Damonte E 2003. Virucidal activity of essential oils from aromatic plants of san Luis, Argentina. Phytotherapy Res 17: 1073-1075.
6. Gubler DJ 2006. Dengue/dengue haemorrhagic fever: history and current status. Novartis Foundation symposium 277. In G Bock, J Goode, New treatment strategies for dengue and other flaviviral diseases, John Wiley, London, p. 3-16.
7. Halle W, Göres E 1987. Prediction of LD50 values by cell culture. Pharmazie 42: 245-248.
8. Hidari KI, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T 2008. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun 376: 91-95.
9. Jain M, Ganju L, Katiyal A, Padwad Y, Mishra KP, Chanda S, Karan D, Yogendra KM, sawhney RC 2008. Effect of Hippophae rhamnoides leaf extract against Dengue virus infection in human blood-derived macrophages. Phytomedicine 15: 793-799.
10. Jassim S, Naji M 2003. Novel antiviral agents: a medicinal plant perspective. J Appl Microb 95: 317-412.
11. Koch C, Reichling J, schneele J, schnitzler P 2008. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 15: 71-78.
12. Leyssen P, De Clercq E, Neyts J 2000. Perspective for the treatment of infections with Flaviviridae. Clin Microb Rev 13: 67-82.
13. Lindenbach B, Rice C 2007. Flaviviridae: the viruses and their replication. In D Knipe D, P Howley, Fields virology, Willians & Wilkins, Philadelphia, p. 991-1041.
14. Meneses R, Ocazionez R, Martínez J, Stashenko E 2009. Inhibitory effect of essential oils obtained from plants grown in Colombia on yellow fever virus replication in vitro. Ann Clin Microbiol Antimicrob [serial on the Internet]. [cited 2009 March 6]; 8: [about 6 p.]. Available from: http://www.ann-clinmicrob.com/articles/browse.asp?date=3-2009.
15. Ono L, Wollinger W, Rocco IM, Coimbra TL, Gorin PA, sierakowski MR 2003. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res 60: 201-208.
16. Pascual M, slowing K, Carretero E, sánchez-Mata D, Villar A 2001. Lippia: traditional uses, chemistry and pharmacology: a review. J Ethnopharmacol 76: 201-214.
17. Patkar Ch, Kuhn R 2006. Development of novel antivirals against flaviviruses. Novartis Foundation symposium 277. In G Bock, J Goode, New treatment strategies for dengue and other flaviviral diseases, John Wiley, London, p. 41-52.
18. Pengsuparp T, Cai H, Fong S, Kinghorn A, Pezzuto J, Wani M, Wall M 1994. Pentacyclic triterpenes derived from Maprouneaafricana are potent inhibitors of HIV-1 reverse transcriptase. J Nat Prod 57: 415-418.
19. Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF 2008. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries. Antiviral Res 80: 135-142.
20. Reis SR, Valente LM, Sampaio AL, Siani AC, Gandini M, Azeredo EL, D'Avila LA, Mazzei JL, Henriques MG, Kubelka CF 2008. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue virus-2. Int Immunopharmacol 8: 468-476.
21. Saddi M, Sanna A, Cottiglia F, Chisu L, Casu L, Bonsignore L, De Logu A 2007. Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in vero cells. Ann Clin Microb Antimicrob 6: 1-10.
22. Schuhmacher A, Reichling J, Schnitzler P 2003. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine 10: 504-510.
23. Siddiqui Y, Ettayebi M, Haddad A, Al-Ahdal M 1996. Effect of essential oils on the enveloped viruses: antiviral activity of oregano and glove oils on herpes simplex virus type 1 and Newcastle disease virus. Med Sci Res 24: 185-186.
24. Stashenko E, Jaramillo E, Martínez R 2004. Comparison of different extraction methods for the analysis of volatile secondary metabolites of Lippia alba (Mill.) N. E. Brown, grown in Colombia and evaluation of its in vitro antioxidant activity. J Chromatogrh 1025: 93-103.
25. Stashenko E, Ruiz C, Muñoz A, Castañeda M, Martínez J 2008. Composition and antioxidant activity of essential oils of Lippia origanoides HBK grown in Colombia. Nat Product Commun 3: 563-566.
26. Sun H, Qiu S, Lin L, Wang Z, Lin Z, Pengsuparp T, Pezzuto J, Fong H, Cordell G 1996. Farnsworth N: nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase. J Nat Prod 59: 525-527.
27. Talarico LB, Duarte ME, Zibetti RG, Noseda MD, Damonte EB 2007. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection. Planta Med 73: 1464-1468.
28. Talarico LB, Pujol CA, Zibetti RG, Faria PC, Noseda MD, Duarte ME, Damonte EB 2005. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res 66: 103-110.
29. Terblanche FC, Kornelius G 1996. Essential oil constituents of the genus Lippia (Verbenaceae) - A literature review. J Essent Oil Res 8: 471-485.
30. Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG 2009. A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53: 1823-1831.
31. Xu H, Zeng F, Wan M, sim K 1996. Anti-HIV triterpene acids from Geum japonicum. J Nat Prod 59: 643-645.
32. Yamasaki K, Nakano M, Kawahata T, Mori H, Otake T, Ueba N, Oishi I, Inami R, Yamane M, Nadamura M, Murata H, Nakanishi T 1998. Anti-HIV-1 activity of herbs in labiates. Biol Pharm Bulletin 21: 829-833.
33. Zhang B, Chen J, Li H, Xu X 1998. Study on the Rheum palmatum volatile oil against HBV in cell culture in vitro. Zhong Yao Cai 21: 524-526.
34. Zhou Z, Khaliq M, suk JE, Patkar C, Li L, Kuhn RJ, Post, CB 2008. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 3: 765-775.